The economics of stone disease

• Verfasst von: Canvasser, Noah E. [VerfasserIn]
• Verfasst von: Alken, Peter [VerfasserIn]
• Titel: The economics of stone disease
• Verf.angabe: Noah E. Canvasser, Peter Alken, Michael Lipkin, Stephen Y. Nakada, Hiren S. Sodha, Abdulkadir Tepeler, Yair Lotan
• Jahr: 2017
• Umfang: 9 S.
• Fussnoten: Published online: 20 January 2017 ; Gesehen am 02.07.2018
• Titel Quelle: Enthalten in: World journal of urology
• Ort Quelle: Berlin : Springer, 1983
• Jahr Quelle: 2017
• Band/Heft Quelle: 35(2017), 9, Seite 1321-1329
• ISSN Quelle: 1433-8726
• DOI: doi:10.1007/s00345-017-2003-y
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1577190270

Abstract

The rising prevalence of kidney stone disease is associated with significant costs to healthcare systems worldwide. This is in part due to direct procedural and medical management costs, as well as indirect costs to health systems, patients, and families. A number of manuscripts evaulating the economics of stone disease have been published since the 2008s International Consultation on Stone Disease. These highlight costs associated with stone disease, including acute management, surgical management, and medical management. This work hopes to highlight optimization in care by reducing inefficient treatments and maximizing cost-efficient preventative strategies.